5 Pulmonary Embolism Clinical Trials in Burlington, NJ (2026)

Q: How do I join a clinical trial in Burlington?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you.

Recruiting Pulmonary Embolism Studies in Burlington

NCT04633655Recruiting

International CIPN Assessment and Validation Study

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an in...

Burlington, NJ1,000 participantsUniversity of Milano Bicocca

View Study Details

NCT04763356Recruiting

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

This is a prospective randomized trial designed to investigate a new care model for patients who suffer from nerve damage from chemotherapy called chemotherapy induced peripheral neuropathy (CIPN). Al...

Burlington, NJ422 participantsUniversity of Vermont

View Study Details

NCT06614322Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain t...

Burlington, NJ190 participantsUniversity of Rochester

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

Burlington, NJ165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT04779554Recruiting

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Peritoneal carcinomatosis from advanced gastro-intestinal malignancy has historically been associated with poor overall survival (≤ 12 months) with few treatment options. Cytoreductive surgery (CRS), ...

Burlington, NJ100 participantsPrakash Pandalai

View Study Details

About Pulmonary Embolism Clinical Trials in Burlington

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 5 pulmonary embolism clinical trials recruiting participants in Burlington, NJ. These studies are seeking a combined 1,877 participants. Research is being sponsored by University of Milano Bicocca, University of Vermont, University of Rochester and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Burlington — FAQ

Are there pulmonary embolism clinical trials in Burlington?

Yes, there are 5 pulmonary embolism clinical trials currently recruiting in Burlington, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Burlington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.

Are clinical trials in Burlington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 5 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov